<DOC>
	<DOCNO>NCT01573754</DOCNO>
	<brief_summary>Porphyria cutanea tarda ( PCT ) iron-related disorder responds treatment phlebotomy low-dose hydroxychloroquine , comparative data treatment limit . The hypothesis hydroxychloroquine noninferior phlebotomy term time remission . Patients well document PCT assign treatment randomization specific criterion meet . All patient follow remission - define achieve normal plasma porphyrin concentration .</brief_summary>
	<brief_title>Hydroxychloroquine Phlebotomy Treating Porphyria Cutanea Tarda</brief_title>
	<detailed_description />
	<mesh_term>Porphyrias</mesh_term>
	<mesh_term>Porphyria , Erythropoietic</mesh_term>
	<mesh_term>Porphyria Cutanea Tarda</mesh_term>
	<mesh_term>Porphyrias , Hepatic</mesh_term>
	<mesh_term>Hydroxychloroquine</mesh_term>
	<criteria>Documented porphyria cutanea tarda ( PCT ) Willing give inform consent Age 18 great Blistering skin lesion due another condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Porphyria , rare disease , orphan disease , iron metabolism</keyword>
</DOC>